Citations (123)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (24)
Shimrit Ringelstein-Harlev. (2020) Immune dysfunction complexity in chronic lymphocytic leukemia ‒ an issue to consider when designing novel therapeutic strategies. Leukemia & Lymphoma 61:9, pages 2050-2058.
Read now
Read now
Audrey Mohr, Marie Cumin, Cristina Bagacean, Pierre Pochard, Christelle Le Dantec, Sophie Hillion, Yves Renaudineau, Christian Berthou, Adrian Tempescul, Hussam Saad, Jacques-Olivier Pers, Anne Bordron & Christophe Jamin. (2019) The regulatory capacity of B cells directs the aggressiveness of CLL. OncoImmunology 8:3.
Read now
Read now
Lucile Sesé, Elisabeth Rivaud, Camille Bron, Véronique Leblond, Emmanuel Raffoux, Elisabeth Longchampt, Pierre Cahen, Leila Zemoura, François Mellot, Louis-Jean Couderc & Emilie Catherinot. (2018) Unexpected Pneumocystis jirovecii pneumonia in patients with untreated chronic lymphocytic leukemia. Leukemia & Lymphoma 59:4, pages 1004-1007.
Read now
Read now
Deepesh Lad, Romy Hoeppli, Qing Huang, Rosa Garcia, Lixin Xu, Cynthia Toze, Raewyn Broady & Megan Levings. (2018) Regulatory T-cells drive immune dysfunction in CLL. Leukemia & Lymphoma 59:2, pages 486-489.
Read now
Read now
Tamar Tadmor, Manfred Welslau & Iwona Hus. (2018) A review of the infection pathogenesis and prophylaxis recommendations in patients with chronic lymphocytic leukemia. Expert Review of Hematology 11:1, pages 57-70.
Read now
Read now
Gilad Itchaki & Jennifer R. Brown. (2017) Lenalidomide in the treatment of chronic lymphocytic leukemia. Expert Opinion on Investigational Drugs 26:5, pages 633-650.
Read now
Read now
Eleni-Eirini Ladikou & Eva Kassi. (2017) The emerging role of estrogen in B cell malignancies. Leukemia & Lymphoma 58:3, pages 528-539.
Read now
Read now
Alakananda Dasgupta, Manoranjan Mahapatra & Renu Saxena. (2015) A study for proposal of use of regulatory T cells as a prognostic marker and establishing an optimal threshold level for their expression in chronic lymphocytic leukemia. Leukemia & Lymphoma 56:6, pages 1831-1838.
Read now
Read now
Outi Laine, Ilona Leppänen, Sirpa Koskela, Jaakko Antonen, Satu Mäkelä, Marjatta Sinisalo, Antti Vaheri & Jukka Mustonen. (2015) Severe Puumala virus infection in a patient with a lymphoproliferative disease treated with icatibant. Infectious Diseases 47:2, pages 107-111.
Read now
Read now
Nashwa Khairat Abousamra, Manal Salah El-Din, Eman Hamza Elzahaf & Mohammed Ebrahim Esmael. (2015) Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1/CD39) as a new prognostic marker in chronic lymphocytic leukemia. Leukemia & Lymphoma 56:1, pages 113-119.
Read now
Read now
Sudy Jahangiri, Jonathan Friedberg & Paul Barr. (2014) Emerging protein kinase inhibitors for the treatment of non-Hodgkin’s lymphoma. Expert Opinion on Emerging Drugs 19:3, pages 367-383.
Read now
Read now
Wilma Barcellini, Francesca G. Imperiali, Anna Zaninoni, Gianluigi Reda, Dario Consonni, Bruno Fattizzo, Silvia Lonati, Lucia Nobili, Alberto Zanella & Agostino Cortelezzi. (2014) Toll-like receptor 4 and 9 expression in B-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression. Leukemia & Lymphoma 55:8, pages 1768-1773.
Read now
Read now
Rachel E. Hayden, Guy Pratt, Claudia Roberts, Mark T. Drayson & Chris M. Bunce. (2012) Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches. Leukemia & Lymphoma 53:4, pages 537-549.
Read now
Read now
Tobias Herold, Till Seiler, Rupert Egensperger, Christoph Trumm, Manuela Bergmann, Daniel Franke, Friederike F. H. Mumm, Nicole Schinwald, Christian Buske & Martin Dreyling. (2012) Progressive multifocal leukoencephalopathy after treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemia. Leukemia & Lymphoma 53:1, pages 169-172.
Read now
Read now
Constantin A Dasanu. (2008) Intrinsic and treatment-related immune alterations in chronic lymphocytic leukaemia and their impact for clinical practice. Expert Opinion on Pharmacotherapy 9:9, pages 1481-1494.
Read now
Read now
Stefan Gattenlohner, Benjamin Etschmann, Burkhard M. Lippert, Hans-Joachim Rumpelt, Hermann Einsele & Hans-Konrad Müller-Hermelink. (2008) Concomitant Herpes simplex and Epstein–Barr virus lymphadenitis with simultaneous lymph node metastases of an occult squamous cell carcinoma in a patient with chronic lymphocytic leukemia. Leukemia & Lymphoma 49:12, pages 2390-2392.
Read now
Read now
Michael Boyiadzis, Kenneth A Foon & Steven Pavletic. (2007) Hematopoietic stem cell transplantation for chronic lymphocytic leukemia: potential cure for an incurable disease. Expert Opinion on Biological Therapy 7:12, pages 1789-1797.
Read now
Read now
Chiara Dell’Agnola & Arya Biragyn. (2007) Clinical utilization of chemokines to combat cancer: the double-edged sword. Expert Review of Vaccines 6:2, pages 267-283.
Read now
Read now
Giovanni D'Arena$suffix/text()$suffix/text() & Nicola Cascavilla. (2007) Chronic lymphocytic leukemia-associated autoimmune hemolytic anemia. Leukemia & Lymphoma 48:6, pages 1072-1080.
Read now
Read now
Jens Rüter, Brian G Barnett, Ilona Kryczek, Michael J Brumlik, Benjamin J Daniel, George Coukos, Weiping Zou & Tyler J Curiel. (2006) Manipulating T regulatory cells in cancer immunotherapy. Expert Review of Dermatology 1:4, pages 589-597.
Read now
Read now
Krzysztof Giannopoulos & Michael Schmitt$suffix/text()$suffix/text(). (2006) Targets and strategies for T-cell based vaccines in patients with B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 47:10, pages 2028-2036.
Read now
Read now
Shahryar Kiaii, Aniruddha Choudhury, Fariba Mozaffari, Reza Rezvany, Jeanette Lundin, Håkan Mellstedt & Anders Österborg. (2006) Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia: long-term effects of fludarabine and alemtuzumab treatment. Leukemia & Lymphoma 47:7, pages 1229-1238.
Read now
Read now
Kalathil Suresh, Graeme Fraser, Elizabeth Scheid, Brian Leber, Jack Gauldie & Ronan Foley. (2006) Generation of in vitro B-CLL specific HLA class I restricted CTL responses using autologous dendritic cells pulsed with necrotictumor lysate. Leukemia & Lymphoma 47:2, pages 297-306.
Read now
Read now
Kalathil Suresh, Juan Carlos Rodriguez-Lecompte, Jack Gauldie & Ronan Foley. (2005) Recent advances in immunotherapy of B-CLL using ex vivo modified dendritic cells. Hematology 10:3, pages 189-203.
Read now
Read now
Articles from other publishers (99)
Valentina Rubino, Flavia Carriero, Anna Teresa Palatucci, Angela Giovazzino, Stefania Leone, Valerio Nicolella, Martina Calabrò, Rosangela Montanaro, Vincenzo Brancaleone, Fabrizio Pane, Federico Chiurazzi, Giuseppina Ruggiero & Giuseppe Terrazzano. (2023) Adaptive and Innate Cytotoxic Effectors in Chronic Lymphocytic Leukaemia (CLL) Subjects with Stable Disease. International Journal of Molecular Sciences 24:11, pages 9596.
Crossref
Crossref
Shimrit Ringelstein‐Harlev, Mona Fanadka, Netanel A. Horowitz, Noam P. Bettman & Tami Katz. (2022) In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T‐cell inhibitory properties, contributing to immunosuppression. European Journal of Haematology 110:4, pages 371-378.
Crossref
Crossref
Catherine C. Coombs, Saumya Easaw, Natalie S. Grover & Susan M. O’Brien. (2023) Cellular Therapies in Chronic Lymphocytic Leukemia and Richter’s Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant. Cancers 15:6, pages 1838.
Crossref
Crossref
Sarah Elitzur, Shai Izraeli, Dina Ben-Yehuda & Moshe E. Gatt. 2023. Clinical Immunology. Clinical Immunology
984
999
.
Stephanos Vassilopoulos, Fadi Shehadeh, Markos Kalligeros, Quynh-Lam Tran, Fred Schiffman & Eleftherios Mylonakis. (2022) Targeted therapies in CLL/SLL and the cumulative incidence of infection: A systematic review and meta-analysis. Frontiers in Pharmacology 13.
Crossref
Crossref
Kai Zhu, Andrew Jamroz, Steven Huang, Diego Villa, Ciara L. Freeman, David W. Scott, Graham Slack, Laurie H. Sehn, Joseph M. Connors, Cynthia L. Toze, Kerry J. Savage & Alina S. Gerrie. (2022) Outcomes of Hodgkin variant Richter transformation in chronic lymphocytic leukaemia and small lymphocytic lymphoma in British Columbia. British Journal of Haematology 198:4, pages 684-692.
Crossref
Crossref
Martin Böttcher, Romy Böttcher-Loschinski, Sascha Kahlfuss, Michael Aigner, Andreas Gießl, Andreas Mackensen, Ursula Schlötzer-Schrehardt, Thomas Tüting, Heiko Bruns & Dimitrios Mougiakakos. (2022) CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints. Cells 11:14, pages 2176.
Crossref
Crossref
Chrysi Galigalidou, Laura Zaragoza-Infante, Anastasia Iatrou, Anastasia Chatzidimitriou, Kostas Stamatopoulos & Andreas Agathangelidis. (2021) Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors. Frontiers in Oncology 11.
Crossref
Crossref
Elisavet Vlachonikola, Kostas Stamatopoulos & Anastasia Chatzidimitriou. (2021) T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia. Cancers 13:13, pages 3255.
Crossref
Crossref
Jennifer A. Whitaker, Sameer A. Parikh, Tait D. Shanafelt, Neil E. Kay, Richard B. Kennedy, Diane E. Grill, Krista M. Goergen, Timothy G. Call, Saad S. Kendarian, Wei Ding & Gregory A. Poland. (2021) The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL). Vaccine 39:7, pages 1122-1130.
Crossref
Crossref
Elisavet Vlachonikola, Kostas Stamatopoulos & Anastasia Chatzidimitriou. (2021) T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword. Frontiers in Immunology 11.
Crossref
Crossref
Mirco Di Marco, Serena Veschi, Paola Lanuti, Alice Ramassone, Stefania Pacillo, Sara Pagotto, Felice Pepe, Jonahunnatha Nesson George-William, Claudia Curcio, Marco Marchisio, Sebastiano Miscia, Idanna Innocenti, Francesco Autore, Barbara Vannata, Patrizia Di Gregorio, Mario Di Gioacchino, Silvia Valentinuzzi, Manuela Iezzi, Renato Mariani-Costantini, Luigi Maria Larocca, Luca Laurenti, Angelo Veronese & Rosa Visone. (2021) Enhanced Expression of miR-181b in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response. Cancers 13:2, pages 257.
Crossref
Crossref
Petra Langerbeins & Barbara Eichhorst. (2021) Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic. Acta Haematologica 144:5, pages 508-518.
Crossref
Crossref
Randall S. Davis. (2020) Roles for the FCRL6 Immunoreceptor in Tumor Immunology. Frontiers in Immunology 11.
Crossref
Crossref
Hanna Bessler, Chiya Moshe Leibovitch & Meir Djaldetti. (2020) Cytokine Release Ensuing Interaction Between Human Peripheral Blood Mononuclears and Epstein-Barr Virus Transformed B-CLL Cell Line. Journal of Immunotherapy and Precision Oncology 3:3, pages 99-104.
Crossref
Crossref
Ricardo García-Muñoz, María-Josefa Nájera, Jesús Feliu, Judith Antón-Remírez, Enrique Ramalle-Gómara, Raquel Marín-Gorricho, Raisa Peralta, Elena Gutiérrez-Gamarra, Jessica Nuñez-Rodriguez, Ricardo Zafra-Morales, Lorea Aguinaga, María-Jose Nebot-Villacampa, Prisma-Monserrat Hernandez-Pérez, Giovanna Farfán-Quiroga, Carlos Panizo & Elena Domínguez-Garrido. (2019) Battle of Thermopylae: 300 Spartans (natural killer cells plus obinutuzumab) versus the immortal warriors (chronic lymphocytic leukemia cells) of Xerxes’ army. Future Science OA 5:10.
Crossref
Crossref
Tina Vosoughi, Marziye Bagheri, Mehran Hosseinzadeh, Ali Ehsanpour, Nader Davari & Najmaldin Saki. (2019) CD markers variations in chronic lymphocytic leukemia: New insights into prognosis. Journal of Cellular Physiology 234:11, pages 19420-19439.
Crossref
Crossref
Burcu Yigit, Ninghai Wang, Elisa ten Hacken, Shih-Shih Chen, Atul K. Bhan, Abel Suarez-Fueyo, Eri Katsuyama, George C. Tsokos, Nicholas Chiorazzi, Catherine J. Wu, Jan A. Burger, Roland W. Herzog, Pablo Engel & Cox Terhorst. (2019) SLAMF6 as a Regulator of Exhausted CD8+ T Cells in Cancer. Cancer Immunology Research 7:9, pages 1485-1496.
Crossref
Crossref
Rashmi Gupta, Wentian Li, Xiao J. Yan, Jacqueline Barrientos, Jonathan E. Kolitz, Steven L. Allen, Kanti Rai, Nicholas Chiorazzi & Patricia K. A. Mongini. (2019) Mechanism for IL-15–Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins. The Journal of Immunology 202:10, pages 2924-2944.
Crossref
Crossref
Moshe E. Gatt & Shai Izraeli. 2019. Clinical Immunology. Clinical Immunology
1049
1063.e1
.
Serena De Matteis, Chiara Molinari, Giulia Abbati, Tania Rossi, Roberta Napolitano, Martina Ghetti, Andrea Ghelli Luserna Di Rorà, Gerardo Musuraca, Alessandro Lucchesi, Gian Matteo Rigolin, Antonio Cuneo, Daniele Calistri, Pier Paolo Fattori, Massimiliano Bonafè & Giovanni Martinelli. (2018) Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients. Journal of Translational Medicine 16:1.
Crossref
Crossref
Rodolfo Patussi Correia, Flávia Amoroso Matos e Silva, Nydia Strachman Bacal, Paulo Vidal Campregher, Nelson Hamerschlak & Gustavo Pessini Amarante-Mendes. (2018) ZAP-70 expression is associated with increased CD4 central memory T cells in chronic lymphocytic leukemia: cross-sectional study. Hematology, Transfusion and Cell Therapy 40:4, pages 317-325.
Crossref
Crossref
Jennifer Gill & Mitchell E. Hughes. (2018) Primer on Chronic Lymphocytic Leukemia: Part I. The Journal for Nurse Practitioners 14:4, pages 302-308.
Crossref
Crossref
Margaux Van Wynsberghe, Pascal Lenain, Fanny Drieux, Dominique Guerrot & Dominique Bertrand. (2017) Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?. Journal of Nephrology 31:2, pages 317-320.
Crossref
Crossref
Jeffrey W. Craig & David M. Dorfman. (2017) Flow Cytometry of T cells and T-cell Neoplasms. Clinics in Laboratory Medicine 37:4, pages 725-751.
Crossref
Crossref
Milena Gusella, Caterina Bolzonella, Rossella Paolini, Elisabetta Rodella, Laura Bertolaso, Cinzia Scipioni, Silvia Bellini, Antonio Cuneo, Felice Pasini & Emilio Ramazzina. (2017) Plasma matrix metalloprotease 9 correlates with blood lymphocytosis, leukemic cell invasiveness, and prognosis in B-cell chronic lymphocytic leukemia. Tumor Biology 39:2, pages 101042831769432.
Crossref
Crossref
Valentina Griggio, Giorgia Mandili, Candida Vitale, Michela Capello, Paolo Macor, Sara Serra, Barbara Castella, Silvia Peola, Myriam Foglietta, Daniela Drandi, Paola Omedé, Daniele Sblattero, Paola Cappello, Roberto Chiarle, Silvia Deaglio, Mario Boccadoro, Francesco Novelli, Massimo Massaia & Marta Coscia. (2016) Humoral immune responses toward tumor-derived antigens in previously untreated patients with chronic lymphocytic leukemia. Oncotarget 8:2, pages 3274-3288.
Crossref
Crossref
Nikolaos Papadopoulos, Melanie Deutsch, Spilios Manolakopoulos, Chrysoula Bitsi, Helias Michalakeas, Helias Poulakidas, Eftychia Tsironi, Stavroula Giannouli, George V. Papatheodoridis, John Koskinas & Dimitrios Pectasides. (2017) Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy. European Journal of Gastroenterology & Hepatology 29:1, pages 56-60.
Crossref
Crossref
Stefano Molica & Aaron Polliack. (2016) Autoimmune hemolytic anemia (AIHA) associated with chronic lymphocytic leukemia in the current era of targeted therapy. Leukemia Research 50, pages 31-36.
Crossref
Crossref
Nadja Zaborsky, Franz Josef Gassner, Daniela Asslaber, Petra Reinthaler, Ursula Denk, Sabine Flenady, Josefina Piñón Hofbauer, Barbara Danner, Stefan Rebhandl, Andrea Harrer, Roland Geisberger, Richard Greil & Alexander Egle. (2016) CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells. Oncotarget 7:31, pages 49459-49469.
Crossref
Crossref
Joseph A. Fraietta, Robert D. Schwab & Marcela V. Maus. (2016) Improving therapy of chronic lymphocytic leukemia with chimeric antigen receptor T cells. Seminars in Oncology 43:2, pages 291-299.
Crossref
Crossref
Lidia Ciszak, Irena Frydecka, Dariusz Wolowiec, Aleksandra Szteblich & Agata Kosmaczewska. (2015) Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody. Tumor Biology 37:3, pages 4143-4157.
Crossref
Crossref
Barbara Sherry, Preetesh Jain, Pui Yan Chiu, Ling Leung, Steven L. Allen, Jonathan E. Kolitz, Kanti R. Rai, Jacquie Barrientos, Spencer Liang, Rachael Hawtin & Nicholas Chiorazzi. (2015) Identification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytes. Immunologic Research 63:1-3, pages 216-227.
Crossref
Crossref
Mohammad Hojjat-Farsangi, Mahmood Jeddi-Tehrani, Amir Hossein Daneshmanesh, Fariba Mozaffari, Ali Moshfegh, Lotta Hansson, Seyed Mohsen Razavi, Ramazan Ali Sharifian, Hodjattallah Rabbani, Anders Österborg, Håkan Mellstedt & Fazel Shokri. (2015) Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia. PLOS ONE 10:11, pages e0142310.
Crossref
Crossref
Franz J. Gassner, Nadja Zaborsky, Kemal Catakovic, Stefan Rebhandl, Michael Huemer, Alexander Egle, Tanja N. Hartmann, Richard Greil & Roland Geisberger. (2015)
Chronic lymphocytic leukaemia induces an exhausted T cell phenotype in the
TCL
1 transgenic mouse model
. British Journal of Haematology 170:4, pages 515-522.
Crossref
Crossref
JINLIN LIU, YONGLIE ZHOU, QIANG HUANG & LIANNV QIU. (2015) CD14+HLA-DRlow/− expression: A novel prognostic factor in chronic lymphocytic leukemia. Oncology Letters 9:3, pages 1167-1172.
Crossref
Crossref
Anne Rissiek, Christian Schulze, Ulrike Bacher, Aneta Schieferdecker, Benjamin Thiele, Anita Jacholkowski, Anna Flammiger, Christiane Horn, Friedrich Haag, Gisa Tiegs, Katja Zirlik, Martin Trepel, Eva Tolosa & Mascha Binder. (2014) Multidimensional scaling analysis identifies pathological and prognostically relevant profiles of circulating T-cells in chronic lymphocytic leukemia. International Journal of Cancer 135:10, pages 2370-2379.
Crossref
Crossref
Rodolfo Patussi Correia, Flávia Amoroso Matos Silva, Nydia Strachman Bacal, Paulo Vidal Campregher, Nelson Hamerschlak & Gustavo P. Amarante-Mendes. (2014) Involvement of memory T-cells in the pathophysiology of chronic lymphocytic leukemia. Revista Brasileira de Hematologia e Hemoterapia 36:1, pages 60-64.
Crossref
Crossref
Georgiana Emilia Grigore, Iuliu C. Ivanov, Mihaela Zlei, Angela Dăscălescu, Roxana Popescu, Tudor Petreuș & Eugen Carasevici. (2014) Specific Associations Between Clinical Signs, Immune Cells, Disease Genetic Background and Burden in a Group of Patients with B-Cell Chronic Lymphocytic Leukemia. Romanian Review of Laboratory Medicine 22:1.
Crossref
Crossref
Pralay K. Sarkar, Paras Malhotra & P. S. Sriram. (2014) Rapid Progression of Pulmonary Blastomycosis in an Untreated Patient of Chronic Lymphocytic Leukemia. Case Reports in Medicine 2014, pages 1-5.
Crossref
Crossref
Iwona Hus, Agnieszka Bojarska-Junak, Sylwia Chocholska, Waldemar Tomczak, Justyna Woś, Anna Dmoszyńska & Jacek Roliński. (2013) Th17/IL-17A Might Play a Protective Role in Chronic Lymphocytic Leukemia Immunity. PLoS ONE 8:11, pages e78091.
Crossref
Crossref
Jason A. DubovskyKyle A. Beckwith, Gayathri NatarajanJennifer A. WoyachSamantha JaglowskiYiming ZhongJoshua D. HesslerTa-Ming LiuBetty Y. ChangKarilyn M. LarkinMatthew R. StefanovskiDanielle L. ChappellFrank W. FrissoraLisa L. SmithKelly A. SmuckerJoseph M. FlynnJeffrey A. JonesLeslie A. AndritsosKami MaddocksAmy M. LehmanRichard FurmanJeff Sharman, Anjali MishraMichael A. CaligiuriAbhay R. Satoskar, Joseph J. BuggyNatarajan MuthusamyAmy J. Johnson & John C. Byrd. (2013) Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood 122:15, pages 2539-2549.
Crossref
Crossref
Emilie Laprevotte, Gregory Voisin, Loïc Ysebaert, Christian Klein, Camille Daugrois, Guy Laurent, Jean-Jacques Fournie & Anne Quillet-Mary. (2013)
Recombinant Human IL-15
Trans
-Presentation by B Leukemic Cells from Chronic Lymphocytic Leukemia Induces Autologous NK Cell Proliferation Leading to Improved Anti-CD20 Immunotherapy
. The Journal of Immunology 191:7, pages 3634-3640.
Crossref
Crossref
Erin C. Hall, Eric A. Engels, Robert A. Montgomery & Dorry L. Segev. (2013) Cancer Risk After ABO-Incompatible Living-Donor Kidney Transplantation. Transplantation 96:5, pages 476-479.
Crossref
Crossref
Christine E. Cutucache. (2013) Tumor-induced host immunosuppression: Special focus on CLL. International Immunopharmacology 17:1, pages 35-41.
Crossref
Crossref
Jorge Monserrat, Miguel Ángel Sánchez, Raquel de Paz, David Díaz, Sonia Mur, Eduardo Reyes, Alfredo Prieto, Antonio de la Hera, Carlos Martínez-A & Melchor Álvarez-Mon. (2013) Distinctive patterns of naïve/memory subset distribution and cytokine expression in CD4 T lymphocytes in ZAP-70 B-chronic lymphocytic patients. Cytometry Part B: Clinical Cytometry, pages n/a-n/a.
Crossref
Crossref
Charalampos PontikoglouMaria-Christina KastrinakiMirjam KlausChristina KalpadakisPavlos KatonisKalliopi AlpantakiGerassimos A. PangalisHelen A. Papadaki. (2013) Study of the Quantitative, Functional, Cytogenetic, and Immunoregulatory Properties of Bone Marrow Mesenchymal Stem Cells in Patients with B-Cell Chronic Lymphocytic Leukemia. Stem Cells and Development 22:9, pages 1329-1341.
Crossref
Crossref
Giovanni D'Arena, Roberto Guariglia, Francesco La Rocca, Stefania Trino, Valentina Condelli, Laura De Martino, Vincenzo De Feo & Pellegrino Musto. (2013) Autoimmune Cytopenias in Chronic Lymphocytic Leukemia. Clinical and Developmental Immunology 2013, pages 1-8.
Crossref
Crossref
Yu Shi, Wei Wu, Tianhong Wan, Yanning Liu, Guoping Peng, Zhi Chen & Haihong Zhu. (2013) Impact of polyclonal anti-CD3/CD28-coated magnetic bead expansion methods on T cell proliferation, differentiation and function. International Immunopharmacology 15:1, pages 129-137.
Crossref
Crossref
Moshe E. Gatt, Dina Ben-Yehuda & Shai Izraeli. 2013. Clinical Immunology. Clinical Immunology
946
961
.
Mercedes Borge, Paula Romina Nannini, Pablo Elías Morande, Carolina Jancic, Alicia Bistmans, Raimundo Fernando Bezares, Mirta Giordano & Romina Gamberale. (2012) CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients. Cancer Immunology, Immunotherapy 62:1, pages 113-124.
Crossref
Crossref
Shahryar Kiaii, Parviz Kokhaei, Fariba Mozaffari, Eva Rossmann, Fatemeh Pak, Ali Moshfegh, Marzia Palma, Lotta Hansson, Kaveh Mashayekhi, Mohammad Hojjat-Farsangi, Anders Österborg, Aniruddha Choudhury & Håkan Mellstedt. (2012) T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile. Cancer Immunology, Immunotherapy 62:1, pages 51-63.
Crossref
Crossref
Karrie K. Wong, Fred Brenneman, Alden Chesney, David E. Spaner & Reginald M. Gorczynski. (2012) Soluble CD200 Is Critical to Engraft Chronic Lymphocytic Leukemia Cells in Immunocompromised Mice. Cancer Research 72:19, pages 4931-4943.
Crossref
Crossref
Aisha Masood, Kasyapa Chitta, Aneel Paulus, A. Nazmul H. Khan, Taimur Sher, Noreen Ersing, Kena C. Miller, Deborah Manfredi, Sikander Ailawadhi, Ivan Borrelo, Kelvin P. Lee & Asher Chanan‐Khan. (2011) Downregulation of BCL2 by AT‐101 enhances the antileukaemic effect of lenalidomide both by an immune dependant and independent manner. British Journal of Haematology 157:1, pages 59-66.
Crossref
Crossref
Jessica M. McDaniel, Javier Pinilla-Ibarz & P. K. Epling-Burnette. (2012) Molecular Action of Lenalidomide in Lymphocytes and Hematologic Malignancies. Advances in Hematology 2012, pages 1-9.
Crossref
Crossref
Bruno Bockorny, Ion Codreanu & Constantin A. Dasanu. (2012) Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature. British Journal of Haematology 156:1, pages 50-66.
Crossref
Crossref
Angélique Biancotto, Pradeep K Dagur, John C Fuchs, Adrian Wiestner, C Bruce Bagwell & J Philip McCoyJrJr. (2012) Phenotypic complexity of T regulatory subsets in patients with B-chronic lymphocytic leukemia. Modern Pathology 25:2, pages 246-259.
Crossref
Crossref
Karin Gustafsson, Katarina Junevik, Olle Werlenius, Sandra Holmgren, Alex Karlsson‐Parra & Per‐Ola Andersson. (2011)
Tumour‐loaded α‐type 1‐polarized Dendritic Cells from Patients with Chronic Lymphocytic Leukaemia Produce a Superior NK‐, NKT‐ and CD8
+
T Cell‐attracting Chemokine Profile
. Scandinavian Journal of Immunology 74:3, pages 318-326.
Crossref
Crossref
Jason A. Dubovsky, John J. Powers, Yang Gao, Luis F. Mariusso, Eduardo M. Sotomayor & Javier A. Pinilla-Ibarz. (2011) Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2′-deoxycytidine. Leukemia Research 35:9, pages 1193-1199.
Crossref
Crossref
Bang‐Ning Lee, Hui Gao, Evan N. Cohen, Xavier Badoux, William G. Wierda, Zeev Estrov, Stefan H. Faderl, Michael J. Keating, Alessandra Ferrajoli & James M. Reuben. (2011) Treatment with lenalidomide modulates T‐cell immunophenotype and cytokine production in patients with chronic lymphocytic leukemia. Cancer 117:17, pages 3999-4008.
Crossref
Crossref
L. Karabon, A. Jedynak, S. Giebel, D. Wołowiec, M. Kielbinski, D. Woszczyk, K. Kapelko‐Slowik, K. Kuliczkowski & I. Frydecka. (2011)
KIR/HLA
gene combinations influence susceptibility to B‐cell chronic lymphocytic leukemia and the clinical course of disease
. Tissue Antigens 78:2, pages 129-138.
Crossref
Crossref
Dianne Pulte, Richard R. Furman, M. Johan Broekman, Joan H.F. Drosopoulos, Harold S. Ballard, Kim E. Olson, Jorge R. Kizer & Aaron J. Marcus. (2011) CD39 Expression on T Lymphocytes Correlates With Severity of Disease in Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma Myeloma and Leukemia 11:4, pages 367-372.
Crossref
Crossref
Jason A. Dubovsky, Daniel Wang, John J. Powers, Emmanuel Berchmans, Matthew A. Smith, Kenneth L. Wright, Eduardo M. Sotomayor & Javier A. Pinilla-Ibarz. (2011) Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers. Leukemia Research 35:3, pages 394-404.
Crossref
Crossref
T. Tadmor, A. Aviv & A. Polliack. (2011) Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties. Annals of Oncology 22:2, pages 250-256.
Crossref
Crossref
Franz Josef Gassner, Lukas Weiss, Roland Geisberger, Josefina Piñón Hofbauer, Alexander Egle, Tanja Nicole Hartmann, Richard Greil & Inge Tinhofer. (2010) Fludarabine modulates composition and function of the T cell pool in patients with chronic lymphocytic leukaemia. Cancer Immunology, Immunotherapy 60:1, pages 75-85.
Crossref
Crossref
John C. Riches, Alan G. Ramsay & John G. Gribben. (2010) T-cell function in chronic lymphocytic leukaemia. Seminars in Cancer Biology 20:6, pages 431-438.
Crossref
Crossref
Simon H. Apte, Penny Groves, Stuart Olver, Adriana Baz, Denise L. Doolan, Anne Kelso & Norbert Kienzle. (2010) IFN-γ Inhibits IL-4–Induced Type 2 Cytokine Expression by CD8 T Cells In Vivo and Modulates the Anti-Tumor Response. The Journal of Immunology 185:2, pages 998-1004.
Crossref
Crossref
Rajendra N. Damle, Carlo Calissano & Nicholas Chiorazzi. (2010) Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells. Best Practice & Research Clinical Haematology 23:1, pages 33-45.
Crossref
Crossref
James A. Walton, Peter M. Lydyard, Amit Nathwani, Vincent Emery, Arne Akbar, Martin J. Glennie & Nino Porakishvili. (2010)
Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4
+
perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype
. British Journal of Haematology 148:2, pages 274-284.
Crossref
Crossref
Abraham Klepfish, Lugassy Gilles, Kotsianidis Ioannis, Rachmilewitz Eliezer & Schattner Ami. (2009) Enhancing the Action of Rituximab in Chronic Lymphocytic Leukemia by Adding Fresh Frozen Plasma. Annals of the New York Academy of Sciences 1173:1, pages 865-873.
Crossref
Crossref
Mary T. Litzinger, Kenneth A. Foon, Helen Sabzevari, Kwong-Yok Tsang, Jeffrey Schlom & Claudia Palena. (2008) Chronic lymphocytic leukemia (CLL) cells genetically modified to express B7-1, ICAM-1, and LFA-3 confer APC capacity to T cells from CLL patients. Cancer Immunology, Immunotherapy 58:6, pages 955-965.
Crossref
Crossref
Nashwa Khayrat Abousamra, Manal Salah EL‐Din & Emad Azmy. (2009) T‐cell CD38 expression in B‐chronic lymphocytic leukaemia. Hematological Oncology 27:2, pages 82-89.
Crossref
Crossref
Jan Cerny, Sa Wang, Patricia Miron, Lloyd Hutchinson & Doreen Brettler. (2008) EBV-negative Hodgkin lymphoma in ZAP-70-positive B-cell lymphocytic leukemia patient. Annals of Hematology 88:5, pages 495-497.
Crossref
Crossref
G. D'Arena & N. Cascavilla. (2009) Chronic Lymphocytic Leukemia-Associated Pure Red Cell Aplasia. International Journal of Immunopathology and Pharmacology 22:2, pages 279-286.
Crossref
Crossref
Inge Tinhofer, Lukas Weiss, Franz Gassner, Gabriele Rubenzer, Claudia Holler & Richard Greil. (2009) Difference in the Relative Distribution of CD4+ T-cell Subsets in B-CLL With Mutated and Unmutated Immunoglobulin (Ig) VH Genes. Journal of Immunotherapy 32:3, pages 302-309.
Crossref
Crossref
Naimish Patel & Henry Koziel. 2009. Pulmonary Infection in the Immunocompromised Patient. Pulmonary Infection in the Immunocompromised Patient
1
28
.
Daniel M. Schreeder, Jicun Pan, Fu Jun Li, Eric Vivier & Randall S. Davis. (2008) FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemia. European Journal of Immunology 38:11, pages 3159-3166.
Crossref
Crossref
Dennis Carney & John Seymour. 2008. Chronic Lymphocytic Leukemia. Chronic Lymphocytic Leukemia
231
260
.
Jeremías Galletti, Cristian Cañones, Pablo Morande, Mercedes Borge, Pablo Oppezzo, Jorge Geffner, Raimundo Bezares, Romina Gamberale & Mirta Giordano. (2008) Chronic Lymphocytic Leukemia Cells Bind and Present the Erythrocyte Protein Band 3: Possible Role as Initiators of Autoimmune Hemolytic Anemia. The Journal of Immunology 181:5, pages 3674-3683.
Crossref
Crossref
Fanny Dujardin, Thierry Lefrancq, Claire Bléchet, Michel Boni-Boka, Delphine Sénecal, Isabelle Desmoulins & Serge Guyétant. (2008) Syndrome de Richter de type pseudohodgkinien. À propos de deux cas et revue de la littérature. Annales de Pathologie 28:4, pages 311-316.
Crossref
Crossref
Je-Jung Lee, Kenneth A Foon, Robbie B Mailliard, Ravikumar Muthuswamy & Pawel Kalinski. (2008) Type 1-polarized dendritic cells loaded with autologous tumor are a potent immunogen against chronic lymphocytic leukemia. Journal of Leukocyte Biology 84:1, pages 319-325.
Crossref
Crossref
Claire Dearden. (2008) Disease-Specific Complications of Chronic Lymphocytic Leukemia. Hematology 2008:1, pages 450-456.
Crossref
Crossref
Moshe E. Gatt, Dina Ben-Yehuda & Shai Izraeli. 2008. Clinical Immunology. Clinical Immunology
1131
1149
.
Dolgor Baatar, Purevdorj Olkhanud, Dianne Newton, Kenya Sumitomo & Arya Biragyn. (2007) CCR4-Expressing T Cell Tumors Can Be Specifically Controlled via Delivery of Toxins to Chemokine Receptors. The Journal of Immunology 179:3, pages 1996-2004.
Crossref
Crossref
Barbara Seliger & Soldano Ferrone. 2007. General Principles of Tumor Immunotherapy. General Principles of Tumor Immunotherapy
123
144
.
Hassan A. Hatoum, Rami A.R. Mahfouz, Zaher K. Otrock, Abdel-Rahman Hudaib, Ali T. Taher & Ali I. Shamseddine. (2007) Acute myeloid leukemia with T-cell receptor gamma gene rearrangement occurring in a patient with chronic lymphocytic leukemia: A case report. American Journal of Hematology 82:1, pages 69-72.
Crossref
Crossref
Katarina Junevik, Olle Werlenius, Sverker Hasselblom, Stefan Jacobsson, Herman Nilsson-Ehle & Per-Ola Andersson. (2006) The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL). Annals of Hematology 86:2, pages 89-94.
Crossref
Crossref
Inge TinhoferGabriele RubenzerClaudia HollerElisabeth HofstaetterMarkus StoecherAlexander EgleMichael SteurerRichard Greil. (2006) Expression levels of CD38 in T cells predict course of disease in male patients with B-chronic lymphocytic leukemia. Blood 108:9, pages 2950-2956.
Crossref
Crossref
Cristina Bertinetti, Katja Zirlik, Kristina Heining-Mikesch, Gabriele Ihorst, Heide Dierbach, Cornelius F. Waller & Hendrik Veelken. (2006) Phase I Trial of a Novel Intradermal Idiotype Vaccine in Patients with Advanced B-Cell Lymphoma: Specific Immune Responses Despite Profound Immunosuppression. Cancer Research 66:8, pages 4496-4502.
Crossref
Crossref
Manuel Alfonso-Pérez, Sonia López-Giral, Nuria E Quintana, Javier Loscertales, Patricia Martín-Jiménez & Cecilia Muñoz. (2006) Anti-CCR7 monoclonal antibodies as a novel tool for the treatment of chronic lymphocyte leukemia. Journal of Leukocyte Biology 79:6, pages 1157-1165.
Crossref
Crossref
Håkan Mellstedt & Aniruddha Choudhury. (2005) T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil. Cancer Immunology, Immunotherapy 55:2, pages 210-220.
Crossref
Crossref
Kristen J. Radford, Frank Vari & Derek N.J. Hart. (2005) Vaccine strategies to treat lymphoproliferative disorders. Pathology 37:6, pages 534-550.
Crossref
Crossref
Ettore Biagi, Raphael Rousseau, Eric Yvon, Mary Schwartz, Gianpietro Dotti, Aaron Foster, Diana Havlik-Cooper, Bambi Grilley, Adrian Gee, Kelty Baker, George Carrum, Lawrence Rice, Michael Andreeff, Uday Popat & Malcolm Brenner. (2005) Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia. Clinical Cancer Research 11:19, pages 6916-6923.
Crossref
Crossref
Marc BeyerMatthias KochanekKamruz DarabiAlexey PopovMarkus JensenElmar EndlPercy A. KnolleRoman K. ThomasMichael von Bergwelt-BaildonSvenja DebeyMichael HallekJoachim L. Schultze. (2005) Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 106:6, pages 2018-2025.
Crossref
Crossref
Sharon Coleman, Aled Clayton, Malcolm D. Mason, Bharat Jasani, Malcolm Adams & Zsuzsanna Tabi. (2005) Recovery of CD8+ T-Cell Function During Systemic Chemotherapy in Advanced Ovarian Cancer. Cancer Research 65:15, pages 7000-7006.
Crossref
Crossref
W.H. Leung, S.F.D. Tsang & C.S. Chim. (2005) Extrapulmonary tuberculous abscess in chronic lymphocytic leukaemia (CLL) treated with fludarabine: Case report and review of literature. American Journal of Hematology 79:3, pages 246-247.
Crossref
Crossref
Wojciech Wojciechowski, Huifen Li, Shannon Marshall, Chiara Dell’Agnola & Igor Espinoza-Delgado. (2005) Enhanced Expression of CD20 in Human Tumor B Cells Is Controlled through ERK-Dependent Mechanisms. The Journal of Immunology 174:12, pages 7859-7868.
Crossref
Crossref
P. Kokhaei, M. Palma, H. Mellstedt & A. Choudhury. (2005) Biology and treatment of chronic lymphocytic leukemia. Annals of Oncology 16, pages ii113-ii123.
Crossref
Crossref
Dominic Fong, Alexandra Kaiser, Gilbert Spizzo, Guenther Gastl & Alexandar Tzankov. (2005) Hodgkin's disease variant of Richter's syndrome in chronic lymphocytic leukaemia patients previously treated with fludarabine. British Journal of Haematology 129:2, pages 199-205.
Crossref
Crossref